Stomach cancer treatment
An increasing number of people are cured of stomach cancer thanks to accurate diagnosis, robot surgery, radiotherapy, etc.
Content |
The main articles are:
How stomach cancer is treated
Ways to treat stomach cancer in 2020:
- Endoscopic resection. Flexible endoscope is introduced into stomach and organ mucosa is removed. The method allows you to cut out tumors of small size at the initial stage and without metastases;
- Laparoscopy. Through small punctures, the surgeon partially or completely removes the organ;
- Surgery with a cut in the abdominal cavity is carried out with contraindications to minimally invasive methods;
- Chemotherapy for stomach cancer in Korea is used if the patient has metastases. It helps prevent relapse. It is used with medicines and immunotherapy, which reduce the side effect and increase immunity;
- Radiotherapy. The RapidArc device directs radiation to the neoplasm and does not touch healthy tissues. The method is used to eliminate the tumor and residual cancer cells without surgery;
- Gamma and cyber knife. The malignancy is destroyed by radioactive radiation at a given point. The rest of the tissues are not injured.
After surgery, the patient must follow a diet that the doctor will develop for him. The recovery time after stomach cancer depends on the patient's well-being and the type of treatment done.
Treatment in countries around the world
For 2020, the result of treatment for stomach cancer in Korea is the highest in the world. Survival within 5 years after gastric cancer therapy is 69%. In Japan, this figure is 60%, in the USA and Germany - 33%[1]. For stomach cancer in Korea, doctors perform 90% of operations using minimally invasive methods. This allows you to maintain a healthy part of the organ and reduce the length of rehabilitation.
Chronicle
2023: Smart capsule created to boost appetite
On April 26, 2023, US researchers at the Massachusetts Institute of Technology (MIT) reported the development of a swallowed capsule that stimulates appetite and prevents the body from wasting as a result of malnutrition. Read more here.
2022: R-Pharm and Rusfarmtech signed an agreement to develop a drug for the treatment of stomach cancer
On April 12, 2022, the R-Pharm Group and the Rusfarmtech research company announced the signing of a global license agreement for the development and commercialization of the antitumor drug Alofanib, intended for the treatment of stomach cancer and a number of other oncological diseases. Read more here.
2021: Amgen buys stomach cancer drug developer Five Prime Therapeutics for $1.9 billion
In early March 2021, Amgen bought the developer of the gastric cancer drug Five Prime Therapeutics for $1.9 billion. Under the agreement, Amgen will pay $38 per Five Prime share, well above the normal market price ($21.26). The deal is expected to close by the end of the second quarter of 2021. Read more here.
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |